Literature DB >> 11667547

A Reductive Alkylation Procedure Applicable to Both Solution- and Solid-Phase Syntheses of Secondary Amines.

Anna K. Szardenings1, Timothy S. Burkoth, Gary C. Look, David A. Campbell.   

Abstract

Entities:  

Year:  1996        PMID： 11667547     DOI： 10.1021/jo960124n

Source DB:  PubMed          Journal:  J Org Chem        ISSN： 0022-3263            Impact factor:   4.354


× No keyword cloud information.
  6 in total

Review 1.  Recent publications in solid-phase chemistry: Part 1.

Authors:  I W James
Journal:  Mol Divers       Date:  1997       Impact factor: 2.943

2.  Iterative approach to the discovery of novel degarelix analogues: substitutions at positions 3, 7, and 8. Part II.

Authors:  Manoj P Samant; Jozsef Gulyas; Doley J Hong; Glenn Croston; Catherine Rivier; Jean Rivier
Journal:  J Med Chem       Date:  2005-07-28       Impact factor: 7.446

3.  A solid-phase approach towards the development of 3-aza-6,8-dioxabicyclo[3.2.1]octane scaffolds.

Authors:  Andrea Trabocchi; Francesco Mancini; Gloria Menchi; Antonio Guarna
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

4.  Exploring solid-phase approaches for the preparation of new beta-lactams from amino acids.

Authors:  Guillermo Gerona-Navarro; Miriam Royo; Ma Teresa García-López; Fernando Albericio; Rosario González-Muñiz
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

5.  Lysosome and HER3 (ErbB3) selective anticancer agent kahalalide F: semisynthetic modifications and antifungal lead-exploration studies.

Authors:  Abbas Gholipour Shilabin; Noer Kasanah; David E Wedge; Mark T Hamann
Journal:  J Med Chem       Date:  2007-08-14       Impact factor: 7.446

6.  Solid-phase synthesis of new Trp(Nps)-containing dipeptide derivatives as TRPV1 channel blockers.

Authors:  Ma Jesús Pérez de Vega; Ma Teresa García-López; Laura Zaccaro; Miriam Royo; Fernando Albericio; Asia Fernández-Carvajal; Antonio Ferrer-Montiel; Rosario González-Muñiz
Journal:  Molecules       Date:  2010-07-15       Impact factor: 4.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.